MedTrace Logo

Struvite Stones Antibiotic Study

NCT02375295 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-05-17

No results posted yet for this study

Summary

The aim of this research is to determine an effective antibiotic regimen following definitive surgical therapy of kidney stones caused by bacterial infection (struvite stones).

Conditions

  • Kidney Stones

Interventions

DRUG

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin

Approved antibiotics used routinely will be given at the physician's discretion with the patient: ciprofloxacin, cotrimoxazole-trimethoprim, or macrodantin

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Ben Chew, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02375295 on ClinicalTrials.gov